Episoder
-
CENTOGENE’s Prof. Peter Bauer and Dr. Jorge Pinto Basto join host Ben Legg to look back on 25 Years since the human genome project was concluded. Today, we are discussing the Human Genome Project – looking at the initial impact, the advancements in the past 20 years, and what the future of genetics and rare disease patient care could look like. Before joining CENTOGENE, Jorge served as the Director of the Molecular Diagnostics and Genomics Labs at CGC Genetics. He holds a medical degree from the University of Porto and is specialized in Rare Disease Genetics, Neurogenetics, Dysmorphology, and Molecular Genetics. Listen in as Dr. Basto and Prof. Bauer share their insights into their journey with genomic testing 25 years later.
-
In this episode of the “Inside Rare Diseases: On a mission for life-changing answers podcast,” Dr. Christine Klein, Head of the Neurogenetic Institute of the University of Lübeck, and CENTOGENE’s Prof. Peter Bauer, M.D., join host Ben Legg to talk about the latest insights into Parkinson’s Disease (PD). Dr. Klein is a Professor of Neurology and Neurogenetics. She has served as the Chair of the Congress Scientific Program Committee of the International Parkinson and Movement Disorder Society and President of the German Neurological Society and currently acts as Chair-Elect of the European Section of the International Parkinson and Movement Disorder Society. Listen in as Dr. Klein and Prof. Bauer share insights into the diagnosis, prognosis, and treatment of Parkinson’s Disease.
-
Mangler du episoder?
-
In this episode of the podcast, “Inside Rare Diseases: On a mission for life-changing answers”, Dr. Katrin Hahn from Charité Berlin University of Medicine and CENTOGENE’s Prof. Peter Bauer join host Ben Legg to talk about the diagnostic challenges surrounding hereditary transthyretin amyloidosis (ATTR). Dr. Hahn is a Neurologist, Senior Physician, and Head of the Hereditary Neuropathies and Amyloidosis Research Group Speaker ACCB and NEURO-AIDS Research Group at the Berlin Charité. Subscribe now to get notified when the episode is released and listen in as Dr. Hahn and Prof. Bauer share insights into the diagnosis, prognosis, and treatment of ATTR.
-
Genetic testing is a powerful tool that provides individuals with insight into their genetic makeup and potential health risks. By identifying genetic mutations or variations, individuals can take proactive steps to maintain their health and prevent the onset of certain conditions. Additionally, genetic testing can help families make informed decisions about reproductive planning and support earlier diagnosis and treatment of inherited conditions.
-
There are over 7,000 rare diseases affecting over 350 million patients around the world – and each patient is unique, with a different genetic makeup and individual medical needs. Join moderator Ben Legg and rare disease expert Prof. Peter Bauer as they explore the challenges and successes of the rare disease community. Listen in to get an inside look into rare diseases as we embark on a mission for life-changing answers.
